BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
WOOF
Petco Health and Wellness Company, Inc.
WOOF has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
WOOF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
WOOF's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
WOOF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $2.87 | — |
| Cheap | 24x | $2.40 | -16% |
| Current | 29x | $2.87 | — |
| Fair | 34x | $3.38 | +18% |
| Expensive | 97x | $9.73 | +239% |
Historical ranges are pointers, not guarantees.
WOOF has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over WOOF on the outlook, with more favorable revenue expectations.
WOOF Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect WOOF's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over WOOF on earnings, with more consistent year-over-year improvement.
WOOF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.25 | +150% |
| Q3 2026 | $0.10 | +$0.20 |
| Q1 2024 | -$4.78 | -1506% |
| Q4 2023 | -$4.56 | -1525% |
| Q3 2023 | $0.14 | -69% |
| Q2 2023 | $0.24 | -65% |
| Q1 2023 | $0.34 | -45% |
| Q4 2022 | $0.32 | -33% |
| Q3 2022 | $0.45 | +55% |
WOOF has returned to profit: it earned $0.10 per share over the past year, after losing money the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over WOOF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over WOOF on profitability, with a higher operating margin.
WOOF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | 0% |
| Q2 2026 | $1.5B | +0.2% |
| Q1 2026 | $1.5B | -2.4% |
| Q4 2025 | $1.5B | -3.1% |
| Q3 2025 | $1.5B | -2.3% |
| Q2 2025 | $1.5B | -2.3% |
| Q1 2025 | $1.6B | -7.3% |
| Q4 2024 | $1.5B | +1.2% |
WOOF's revenue grew through 2021 and has held roughly level since: $1.5B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.2% | +0.3 points |
| Q2 2026 | 1.6% | +0.5 points |
| Q1 2026 | 2.1% | +1 points |
| Q4 2025 | 2% | +1.7 points |
| Q3 2025 | 2.9% | +2.7 points |
| Q2 2025 | 1.1% | +2.2 points |
| Q1 2025 | 1.1% | +1.1 points |
| Q4 2024 | 0.3% | +83 points |
WOOF's operating margin was 3.2% last quarter, about level with the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
WOOF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $129.9M | +142% |
| Q2 2026 | -$69.1M | -$25.3M |
| Q1 2026 | $116.4M | +97% |
| Q4 2025 | $60.6M | +$70.9M |
| Q3 2025 | $53.8M | +28% |
| Q2 2025 | -$43.9M | -$2.8M |
| Q1 2025 | $59M | +$61.1M |
| Q4 2024 | -$10.3M | +$17.8M |
WOOF has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
WOOF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 5.0x | High |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 6.9x | High |
| Q4 2024 | 7.7x | High |
WOOF has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
WOOF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.7 | Neutral |
| Stochastic | 58.5 | Neutral |
WOOF's weekly RSI is 57 (neutral) and its Stochastic is 58 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over WOOF on valuation relative to its sector.
WOOF PE vs Consumer Cyclical Sector
| Metric | WOOF | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 59% above |
| PE % | 33 | 50 | 17 pts below |
WOOF is trading at 29x earnings, a 59% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
WOOF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.49 | 15% above |
| 20 week MA | $2.59 | 11% above |
| 50 week MA | $2.72 | 5.5% above |
| 100 week MA | $2.99 | 4% below |
| 200 week MA | $4.12 | 30% below |
WOOF has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
WOOF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.7 | $19.7 | -29% |
| 2022 | $19.7 | $9.31 | -53% |
| 2023 | $9.31 | $3.16 | -66% |
| 2024 | $3.16 | $4.10 | +30% |
| 2025 | $4.10 | $2.93 | -29% |
| 2026 YTD | $2.93 | $2.87 | -2% |
WOOF has the edge over BABA on returns for 2026, with the stronger performance.